You are here: Industry Insights > hospira

News List

Bacteriostatic Water recalled due to a potential lack of sterility assurance europeanpharmaceuticalreview
September 12, 2019
Bacteriostatic Water is being recalled because of a lack of sterilisation confirmation for some vials.
US court rules in favour of Lilly in Alimta® patent lawsuit europeanpharmaceuticalreview
August 13, 2019
The US District Court has ruled in favour of Eli Lilly in the Alimta patent lawsuit against Dr. Reddy’s Laboratories and Hospira, Inc.
Mylan and Hospira both recall injected drugs after particulate discovered in vials fiercepharma
March 20, 2019
Mylan and Hospira are both recalling injected medications because potentially dangerous particulate has been discovered in them.
Pfizer still unable to get on top of problems at Hospira injectables plant fiercepharma
December 14, 2018
Since Pfizer’s Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the essential but troubled injectables facility.
Hospital-backed Civica Rx nabs Amgen veteran as CEO and targets 14 drugs to knock off fiercepharma
September 07, 2018
Civica Rx has support from 120 U.S. hospitals in its effort to fight hospital drug shortages.
Hospira Issues Voluntary Nationwide Recall for one Lot of 25% Dextrose Injection americanpharmaceuticalreview
April 27, 2017
Hospira is voluntarily recalling one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.